Comparison of the effects of Mylabris and Acanthopanax senticosus on promising cancer marker polyamines in plasma of a Hepatoma-22 mouse model using HPLC-ESI-MS

Biomedical Chromatography

Volumn 27, Issue 2, 2013, Pages 208-215

  Wang, Qian ^a   Wang, Yixiang ^a   Liu, Ran ^a   Yan, Xu ^a   Li, Yujiao ^a   Fu, Hui ^a   Bi, Kaishun ^a   Li, Qing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Acanthopanax senticosus; Hepatoma 22 mouse model; Mylabris; Polyamines

Indexed keywords

AMINES; BIOCHEMISTRY; MAMMALS;

ACANTHOPANAX SENTICOSUS; CANCER MARKERS; HEPATOMA-22 MOUSE MODEL; HPLC-ESI MS; MICE MODELS; MYLABRIS; POLYAMINES; SENSITIVE METHOD; SIMPLE METHOD; SIMULTANEOUS DETERMINATIONS;

DISEASES;

ANTINEOPLASTIC AGENT; CARBON; CYCLOPHOSPHAMIDE; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; HERBACEOUS AGENT; METHANOL; MYLABRIS EXTRACT; POLYAMINE; TUMOR MARKER; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEETLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ELEUTHEROCOCCUS SENTICOSUS; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLASMA; SEPARATION TECHNIQUE;

ELEUTHEROCOCCUS SENTICOSUS; MUS; MYLABRIS;

EID: 84871964217     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2777     Document Type: Article

References (34)

1. Berdinskikh NK, Ignatenko NA, Zaletok SP, Ganina KP and Chomiy VA. Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. International Journal of Cancer 1991; 47: 496.
2. Dongdong W, Yanfeng G, Lixiang C, Yuanming Q, Qiaozhen K, Haili W, Linyu Z, Yong Y and Mingxia Z. Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice. Peptides 2010; 31: 850-864.
3. Gabriele R, Thomas E, Karen H and Ralf-Ingo E. Regional distribution of ornithine decarboxylase activity and polyamine levels in experimental cat brain tumors. Neurochemistry International 2001; 39: 135-140.
4. Graziano MJ, Pessah IN and Casida JE. Partial characterization of specific cantharidin binding sites in mouse tissue. Molecular Pharmacology 1988; 33: 706-712.
5. Han SB, Yoon YD, Ahn HJ, Lee HS, Lee CW and Yoon WK. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. International Journal of Immunopharmacology 2003; 3: 1301-1312.
6. Hobbs CA, Paul BA and Gilmour SK. Deregulation of polyamine biosynthesis alters intrinsic histone acethltransferase and deacetylase activities in murine skin and tumors. Cancer Research 2002; 62: 67-74.
7. Jeong HJ, Koo HN, Myung NI, Shin MK, Kim JW, Kim DK, Kim KS, Kim HM and Lee YM. Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian Ginseng. Immunopharmacology and Immunotoxicology 2001; 23: 107-117.
8. Khuhawar MY and Qureshi GA. Polyamines as cancer markers: applicable separation methods. Journal of Chromatography B 2001; 764: 385-407.
9. Kubo S, Tamori A, Nishiguchi S, Omura T, Kinoshita H, Hirohashi K, Kuroki T and Otani S. Relationship of polyamine metabolism to degree of malignancy of human hepatocellular carcinoma. Oncology Reports 1998; 5: 1385-1388.
10. Kurihara H, Matsuzaki S, Yamazaki H, Tsukahara T and Tamura M. Relationship between tissue polyamine levels and malignancy in primary brain tumors. Neurosurgery 1993; 32: 372.
11. Lee SH, Kim SO, Lee HD and Chung BC. Estrogens and polyamines in breast cancer: their profiles and values in disease staging. Cancer Letter 1998; 133: 47-56.
12. Leveque J, Burtin F, Catros-Quemener V, Havouis R and Moulinoux JP. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Anticancer Research 1998; 18: 2663-2668.
13. Lifeng Q and Zirong X. In vivo antitumor activity of chitosan nanoparticles. Bioorganic & Medicinal Chemistry Letters 2006; 16: 4243-4245.
14. Morgan DM. Polyamines: an overview. Molecular Biotechnology 1999; 11: 229-250.
15. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochemical Journal 1986; 234: 249-262.
16. Ran L, Ying J, Weiming C, Junhong L, Lili L, Kaishun B and Qing L. Determination of polyamines in human urine by precolumn derivatization with benzoyl chloride and high-performance liquid chromatography coupled with Q-time-of-flight mass spectrometry. Talanta 2011; 83: 751-756.
17. Rohn G, Eis T, Hell K and Ernestus RI. Regional distribution of ornithine decarboxylase activity and polyamine levels in experimental cat brain tumors. Neurochemistry International 2001; 39: 135-140.
18. Ronglai Z, Qiangou L, Jusheng W, Yanggu X, Tianwen Y and Wei G. Clinical Research Progress. Beijing Publishing House: China, 2000; 13.
19. Russell DH. Increased polyamine concentrations in the urine of human cancer patients. Nature 1971; 233: 144-145.
20. Russell DH. Clinical relevance of polyamines as biochemical markers of tumor kinetics. Clinical Chemistry 1977; 23: 22-27.
21. Russell DH, Levy CC, Schimpff SC and Hawk IA. Urinary polyamines in cancer patients. Cancer Research 1971; 31: 1555.
22. Satoru W, Shoichi S, Sumika N, Kazuaki S and Seitaro O. Choice of vincristine or 6-mercaptopurine on the basis of polyamine level in tumor-bearing regions of the brain. Cancer Letters 1999; 139: 51-58.
23. Schmeda-Hirschmann G, Villasenor-Garcia MM, Lozoya X and Puebla-Perez AM. Immunomodulatory activity of Chilean Cyttaria species in mice with L5178Y lymphoma. Journal of Ethnopharmacology 2001; 77: 253-257.
24. Schmolz MW, Sacher F and Aicher B. The synthesis of Rantes, G-CSF, IL-4, IL-5, IL-6, IL-12 and IL-13 in human whole-blood cultures is modulated by an extract from Eleutherococcus senticosus L. roots. Phytotherapy Research 2001; 15: 268-270.
25. Steven K-HH HH, Lee HH, Der-Zen L and Chien-Chih W. Cantharidin-induced cytotoxicity and cyclooxy genase 2 expression in human bladder carcinoma cell line. Toxicology 2006; 223: 136-143.
26. Taek Joon Y, Yung Choon Y, Seok-Won L, Kwang-Soon S, Won-Hee C, Soo-Hyun H, Eun Suk H, Sung Kee J, Sung-Hoon K and Woo-Mun P. Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. Journal of Ethnopharmacology 2004; 93: 247-253.
27. Tagwireyi D, Ball DE, Loga PJ and Moyo S. Cantharidin poisoning due to 'Blister beetle' ingestion. Toxicon 2000; 38: 1865-1869.
28. Teti D, Visalli M and McNair H. Analysis of polyamines as markers of (patho) physiological conditions. Journal of Chromatography B 2002; 781: 107-149.
29. Thomas T and Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cellular and Molecular Life Sciences 2001; 58: 244-258.
30. Wallace HM, Fraser A and Hughes A. A perspective of polyamine metabolism. Biochemical Journal 2003; 376: 1-14.
31. Wang GS. Medical uses of mylabris in ancient China and recent studies. Journal of Ethnopharmacology 1989; 26: 147-162.
32. Wei W, Ximei W and Yuanjian L. Experimental Methodology of Pharmacology. People's Medical Publishing House: China, 2010; 1587.
33. Yi JM, Kim MS, Seo SW, Lee KN, Yook CS and Kim HM. Acanthopanax senticosus root inhibits mast cell-dependent anaphylaxis. Clinica Chimica Acta 2001; 312: 163-168.
34. Zhiyu Q. Experiments of chemotherapeutic drugs. In Experiment and Guide for Pharmacology. The Medicine Science and Technology Press of China: China, 2010; 377.